Novo Nordisk reports – and has done so since 2002 – in accordance with the Global Reporting Initiative’s (GRI’s) 2002 Sustainability Reporting Guidelines. The Guidelines require reporting in accordance with 11 principles and against a list of 142 indicators, including 97 sustainability performance indicators.
Reporting in accordance with the GRI Guidelines requires meeting five conditions:
Reporting on numbered elements in Sections 1 to 3 of Part C of the Guidelines. These can be found in the GRI Index table.
Vision and strategy Description of the company’s strategy with regard to sustainability, including a statement from the CEO.
Governance structure and management systems Description of organisational structure, policies and management systems, including stakeholder engagement efforts.
Performance indicators Measures of the impact or effect of the company divided into integrated, economic, environmental and social performance indicators.
Include a GRI Content Index as specified in Section 4 of Part C; – a table identifying where the information is located in the report. A summary of this can be found in the printed report on page 40 and in full in the GRI Index table. To make reporting more transparent, Novo Nordisk has chosen two levels of reporting. Where reporting covers all aspects of the indicator, this is marked as fully reported. Where reporting covers only some aspects of the indicator, this is marked as not reported.
Respond to each core indicator in Section 5 of Part C by either (a) reporting on the indicator or (b) explaining the reason for the omission of each indicator. These can be found in the GRI Index table.
Ensure that the report is consistent with the principles in Part B of the Guidelines. These principles are grouped in four clusters which:
Inform decisions about access to the report (clarity, timeliness) An overview of how Novo Nordisk reports in respect of these principles can be found in Reporting Principles
Include the following statement signed by the board or CEO: “This report has been prepared in accordance with the 2002 GRI Guidelines. It represents a balanced and reasonable presentation of our organisation’s economic, environmental, and social performance.”
This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.
